VistaGen Therapeutics (VTGN) USPTO patents

Utility

Synthesis of 4-chlorokynurenines and intermediates

30 Aug 22

The invention relates to an overall enantio-specific synthesis of 4-chlorokynurenine compounds, in particular L-4-chlorokynurenine, with improved yields.

Daniel Levin, Peter Leeming, Emerich Eisenreich, Xuejun Karl Liu

Filed: 11 Feb 19

Utility

Genetic Variants Associated with Response to Treatment of Neurological Disorders

30 Jun 22

Method of treating depression, major depressive disorder, suicidal ideation and related disorders are described by administering L-4-chlorokynurenine (L-4-CI-KYN) to a subject based on their genotype.

Ralph H. SNODGRASS

Filed: 9 Apr 20

Utility

Synthesis of 4-CHLOROKYNURENINES and Intermediates

9 Sep 21

The invention relates to an overall enantio-specific synthesis of 4-chlorokynurenine compounds, in particular L-4-chlorokynurenine, with improved yields.

Daniel LEVIN, Peter LEEMING, Emerich EISENREICH, Xuejun Karl LIU

Filed: 11 Feb 19

Utility

Dosage forms and therapeutic uses of L-4-chlorokynurenine

2 Nov 20

Compositions of L-4-chlorokynurenic are provided, as are methods for the treatment of neurological dysfunction.

H. Ralph Snodgrass, Allen E. Cato, Jack S. Hicklin

Filed: 7 Jun 18

Utility

Dosage forms and therapeutic uses of L-4-chlorokynurenine

27 Apr 20

Compositions of L-4-chlorokynurenine are provided, as are methods for the treatment of neurologica dyslinction.

H. Ralph Snodgrass, Allen E. Cato, Jack S. Hicklin

Filed: 13 May 18

Utility

Dosage forms and therapeutic uses of L-4-chlorokynurenine

13 Apr 20

Compositions of L-4-chlorokynurenine are provided, as are methods for the treatment of neurological dysfunction.

H. Ralph Snodgrass, Allen E. Cato, Jack S. Hicklin

Filed: 7 Jun 18

Utility

Therapeutic Uses of L-4-CHLOROKYNURENINE

23 Oct 19

Pharmaceutical compositions comprising L-4-chlorokynurenine and associated therapeutic methods are provided for the treatment of certain neurological and other conditions.

H. Ralph SNODGRASS

Filed: 5 May 19